Lu M - Search Results

1

[Epirubicin combined with DDP and 5-Fu for treatment of advanced gastric cancer].

Lu M, Shen L, Li J, Li Y, Zhang XD. Lu M, et al. Zhonghua Zhong Liu Za Zhi. 2009 May;31(5):392-5. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19799092 Clinical Trial. Chinese.

2

[Construction and expression of anti-human CD3 chimeric antibody gene and preliminary study of expressed product].

Lu M, Lai CN, Yu M, Guo N, Li Y, Shen BF. Lu M, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 Jan;21(1):43-5, 49. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005. PMID: 15629081 Chinese.

3

[Anti-CD28 antibody costimulation enhances anti-CD3 antibody activating T cells and lowering TGF-beta expression in vitro].

Lou Q, Lü M, Yu M, Li Y. Lou Q, et al. Among authors: lu m. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Jun;14(3):547-51. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 16800940 Chinese.

4

[Retrospective study on regimens of capecitabine-based chemotherapy in the treatment for advanced gastric cancer].

Zhang J, Xiao Y, Lu M, Li J, Zhang XD, Li Y, Shen L. Zhang J, et al. Among authors: lu m. Zhonghua Zhong Liu Za Zhi. 2009 Apr;31(4):312-5. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19615292 Chinese.

5

[Oxaliplatin-based regimen for the treatment of advanced or metastatic gastric/esophagogastric junction cancer].

Li J, Lu M, Shen L, Zhang XD, Li Y. Li J, et al. Among authors: lu m. Zhonghua Zhong Liu Za Zhi. 2009 Dec;31(12):933-6. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 20193337 Chinese.

6

Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel.

Gao J, Lu M, Yu JW, Li YY, Shen L. Gao J, et al. Among authors: lu m. BMC Cancer. 2011 May 18;11:177. doi: 10.1186/1471-2407-11-177. BMC Cancer. 2011. PMID: 21586171 Free PMC article.

7

Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer.

Li Y, Yang Y, Lu M, Shen L. Li Y, et al. Among authors: lu m. Hepatogastroenterology. 2011 Nov-Dec;58(112):2166-70. doi: 10.5754/hge11753. Hepatogastroenterology. 2011. PMID: 22024091

8

The assessment of clinicopathological features, therapy pattern and survival benefit of 162 gastric cancers with liver metastases.

Li J, Lu M, Li J, Zhang X, Li Y, Zhan X, Shen L. Li J, et al. Among authors: lu m. Hepatogastroenterology. 2013 May;60(123):628-32. doi: 10.5754/hge12729. Hepatogastroenterology. 2013. PMID: 23108083

9

Expressions of Thymidylate Synthase,Thymidine Phosphorylase, Class III β-tubulin, and Excision Repair Cross-complementing Group 1predict Response in Advanced Gastric Cancer Patients Receiving Capecitabine Plus Paclitaxel or Cisplatin.

Lu M, Gao J, Wang XC, Shen L. Lu M, et al. Chin J Cancer Res. 2011 Dec;23(4):288-94. doi: 10.1007/s11670-011-0288-8. Chin J Cancer Res. 2011. PMID: 23358102 Free PMC article.

10

UGT1A1 6/28 polymorphisms could predict irinotecan-induced severe neutropenia not diarrhea in Chinese colorectal cancer patients.

Gao J, Zhou J, Li Y, Lu M, Jia R, Shen L. Gao J, et al. Among authors: lu m. Med Oncol. 2013;30(3):604. doi: 10.1007/s12032-013-0604-x. Epub 2013 May 18. Med Oncol. 2013. PMID: 23686699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,396 results

Search Page

Filters